Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms

Circulation

Volumn 112, Issue 14, 2005, Pages 2096-2101

  Schumacher, Burghard ^a   Gietzen, Frank H ^a   Neuser, Hans ^a   Schümmelfeder, Joachim ^a   Schneider, Michael ^a   Kerber, Sebastian ^a   Schimpf, Rainer ^b   Wolpert, Christian ^b   Borggrefe, Martin ^b  

^a Center of Cardiovascular Medicine   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Arrhythmia; Cardiomyopathy; Electrophysiology; Hypertrophy

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR ENDOCARDIUM ELECTROCARDIOGRAM; CLINICAL ARTICLE; ELECTROANATOMIC VOLTAGE MAPPING; ELECTROCARDIOGRAM; ENDOCARDIUM; EPICARDIUM MAPPING; FEMALE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM; HEART VENTRICLE SEPTUM HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MUSCLE POTENTIAL; PRIORITY JOURNAL; SINUS RHYTHM; STIMULUS TO V INTERVAL;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROPHYSIOLOGY; HEART; HEART SEPTUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SYNCOPE; VENTRICULAR FUNCTION, LEFT;

EID: 26944448894     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.515643     Document Type: Article

References (16)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;42:1687-1713.
2. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral based patient population. Circulation. 2000;102:858-864.
3. Maron BJ, Shen WK, Link MS, Alquist AK, Daubert GP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365-373.
4. Varnva AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2001;88:275-279.
5. Kuck KH, Kunze KP, Schluter M, Nienaber CA, Costard A. Programmed electrical stimulation in hypertrophic cardiomyopathy: results in patients with and without cardiac arrest or syncope. Eur Heart J. 1988;9:177-185.
6. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Vanava A, Mahon NG, McKenna WG. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36: 2212-2218.
7. Spirito P, Bellone P, Harris KM, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778-1785.
8. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliot MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156-2164.
9. Moon JCC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003; 41:1561-1567.
10. Kim RJ, Judd RM. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 2003;41:1568-1572.
11. Ferrans VJ, Morrow AG, Roberts WC. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: a study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation. 1972;45: 769-792.
12. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol. 2000;31:988-998.
13. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986;55:575-581.
14. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation. 1997;95:1611-1622.
15. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101: 1288-1296.
16. Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA, Simpson IA, McKenna WJ. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation. 1992;86:467-474.